Drug Interactions between HIV Protease Inhibitors and Acid-Reducing Agents

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.47, Iss.2, 2008-01, pp. : 75-89

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Interactions of HIV Protease Inhibitors

By Malaty L.I.

Drug Safety, Vol. 20, Iss. 2, 1999-02 ,pp. : 147-169

Adis International

Access to resources Recommend Favorite

HIV protease inhibitors based on amino acid derivatives

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 4, 2003-04 ,pp. : 547-550

Informa Healthcare

Access to resources Recommend Favorite

Drug Interactions of Tipranavir, a New HIV Protease Inhibitor

Drug Metabolism Letters, Vol. 1, Iss. 1, 2007-01 ,pp. : 81-84

Bentham Science Publishers

Access to resources Recommend Favorite

Interactions of the Dimeric Triad of HIV-1 Aspartyl Protease with Inhibitors

By MAGER PETER DE CLERCQ ERIK FROEYEN MATHEUS REINHARDT ROBERT

Drug Design and Discovery, Vol. 18, Iss. 2-3, 2003-04 ,pp. : 53-64

Taylor & Francis Ltd

Access to resources Recommend Favorite

Prospects for the Resistance to HIV Protease Inhibitors: Current Drug Design Approaches and Perspectives

Current Pharmaceutical Design, Vol. 11, Iss. 24, 2005-01 ,pp. : 3077-3090

Bentham Science Publishers

Access to resources Recommend Favorite